Jump to top menu Jump to main menu Jump to content
Zsofía Igloi
Researcher

Dr. Zs. (Zsofia) Igloi

Researcher

Researcher

  • Department
  • Virology
  • Focus area
  • Public Health, diagnostics, arbo- and emerging viruses
Contact   External Profile

About Dr. Zs. (Zsofia) Igloi

Introduction

My name is Zsofia Igloi. I was born and raised in Hungary and have lived abroad since 2007, residing in several countries before settling in the Netherlands in 2016. Naturally curious, I’ve always been drawn to research—seeking answers to those timeless “why?” questions.

Transitioning to public health in 2016 proved to be the pivotal move of my career, revealing my true professional passion: delivering high impact, population level projects that make a tangible difference. With a broad range of interests and experience, I thrive on juggling diverse, simultaneous initiatives.

 

Field(s) of expertise

public health, diagnostics, arbo- and emerging viruses 

Education and career

Professional development

After completing my BSc and MSc in biology at the University of Szeged (Hungary) in 2007, I moved to the United Kingdom to pursue a PhD at the University of Leeds, followed by a post doctoral fellowship. My doctoral research centered on hepatitis C virus, where I investigated key cellular interactions and evaluated potential drug targets.

In 2015, I joined Public Health England’s Ebola response team, spending three months in Sierra Leone as a laboratory technician and manager. This field experience opened piqued my interest in public health.

From 2016 to 2018, I completed the EUPHEM fellowship at the Dutch National Institute for Public Health and the Environment (RIVM)—an ECDC funded training program. The fellowship trained me as a public health microbiologist and equipped me with advanced epidemiological tools for disease surveillance and outbreak response.

Since 2019, I have joined the Erasmus MC’s arbovirus and emerging virus reference laboratory in a researcher function. In this role, amongst others, I oversee laboratory preparedness, drive applied research, develop and implement diagnostic assays, and serve as the focal point for the WHO Yellow Fever Laboratory Working Group.

Key achievements at Erasmus MC

  1. COVID 19 response: Led multiple assay evaluation studies for antibody and antigen rapid tests, including large scale community testing of antigen kits in Rotterdam.
  2. iMONSTER biobanking initiative: Conceived and launched a novel biobank that fills a critical gap by collecting diverse specimen types from individuals infected with exotic viruses, thereby facilitating future diagnostic development and validation.
  3. Yellow fever network leadership: Produced comprehensive guidelines, authored manuscripts, and fostered collaborations across the Yellow Fever Laboratory Network, strengthening regional diagnostic capacity.
     

Publications

You can find my publications: here

My Groups